glp 1 agonists and anesthesia Perioperative management of patients taking glucagon-like peptide receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement One-Week GLP-1 Agonist Hold Not
Description
doi: 10.1093/ajcn/83.1.89
To help visualise the expected weight loss at different doses, let's look at this comparative table: These percentages represent average weight loss from baseline over a 68-72 week period, based on the SURMOUNT-1 trial for Mounjaro and the STEP-1 trial for Wegovy
Current prices on GoodRx show $900/month for Ozempic and $1400/month for Wegovy
[DOI] [PubMed] [Google Scholar] 86.Monami M., Nreu B., Scatena A., Cresci B., Andreozzi F., Sesti G., Mannucci E
The other three DPP-4 inhibitors, teneligliptin, anagliptin and trelagliptin, are only approved in the Japanese and Korean markets
